Our Approach
Our goal is to repurpose previously approved therapeutics to address unmet needs for high priority infectious diseases as defined by the NIH or CDC.
Our Story
Shield Pharma was founded in 2014 as a spinoff of the Keck Graduate Institute. It works closely with KGI to bring to market scientific discoveries identified in the Shilman Lab.
Meet the Team
The founders and employees of Shield Pharma work to commercialize our technologies and bring them to market.
Mikhail Martchenko Shilman
Founder & CSO
Mikhail is the inventor of Shield’s technology, a faculty member at KGI, a researcher on infectious diseases and an expert on host-based therapies.
Joel West
Founder & CEO
An experienced software entrepreneur, Joel is a faculty member at KGI, and veteran researcher on innovation and entrepreneurship.
TBD
CTO
Details to follow